Human Factor XII congenital deficicent plasma >5%

Frozen

Packaging options

6-PPD12C	Vial	Minimum 50 mL

Plasma from a human donor with congenital FXII deficiency.

Description of the Human Factor XII congenital deficicent plasma >5%

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Advantages

Minimize test time.
Ready to use.

Informations

Factor XII (FXII) is a glycoprotein synthesized in the evening.
FXII participates in the contact phase which initiates the intrinsic pathway of coagulation.
Activated on contact with a negatively charged surface, it becomes capable of activating prekallikrein and kallikrein (amplified by KHPM) then FXI to FXIa in the presence of KHPM.
The FXIa thus formed activates the FXII in FXIIa, amplifying the reaction.

product sheet

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

Human Factor XII congenital deficicent plasma >5%

Price list, safety data sheets and notices are accessible to our registered customers.

My personal Space

Nouveau client

Human Factor XII congenital deficicent plasma >5%

Price list, safety data sheets and notices are accessible to our registered customers.

Associated products

Human Factor II congenital deficient plasma >5%

Human Factor IX congenital deficient plasma (severe <1%)

Human Factor IX congenital deficient plasma >5%

Human Factor V congenital deficient plasma (severe <1%)

Human Factor V congenital deficient plasma >5%

Human Factor VII congenital deficient plasma (severe <1%)

Human Factor VII congenital deficient plasma >5%

Human Factor VIII congenital deficient plasma (severe <1%)

Human Factor VIII congenital deficient plasma >5%

Human Factor X congenital deficient plasma (severe <1%)

Human Factor X congenital deficient plasma >5%

Human Factor XI congenital deficient plasma (severe <1%)

Human Factor XI congenital deficient plasma >5%

Human Factor XII congenital deficient plasma (severe <1%)

Human Factor XIII congenital deficient plasma (severe <1%)

Human Factor XIII congenital deficient plasma >5%